Immix Biopharma, Inc. IMMX Change in Income Taxes
Change in Income Taxes at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInIncomeTaxesReceivable.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s change in income taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s change in income taxes?
- Immix Biopharma, Inc. (IMMX) reported change in income taxes of $725 in Q1 2026.
- How has Immix Biopharma, Inc.'s change in income taxes changed year-over-year?
- Immix Biopharma, Inc.'s change in income taxes increased by 100.0% year-over-year, from -$2M to $725.
- What is the long-term trend for Immix Biopharma, Inc.'s change in income taxes?
- Over 3 years (2021 to 2025), Immix Biopharma, Inc.'s change in income taxes has grown at a 176.3% compound annual growth rate (CAGR), from -$97.67K to -$2.06M.
- What does change in income taxes mean?
- Change in income tax receivables and payables, reflecting timing between tax accruals and cash payments.